Class II
Terminated
Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in Czech Republic by: Teva Czech Industries, s.r.o.
Why: Packaging defect: observed packaging defect, blister packaging inadequately sealed.
- Company
- The Harvard Drug Group
La Vergne, TN, United States - Reported
- Mar 8, 2023
- Recall started
- Feb 23, 2023
- Ended
- Apr 30, 2024
- Where sold
- Distributed Nationwide in the USA
- Amount
- 17,586 cartons
- Full product description
- Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in Czech Republic by: Teva Czech Industries, s.r.o. Opava-Komarov, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, Packaged and Distributed by: Major Pharmaceuticals Indianapolis, IN 46268 USA. NDC 0904-7257-61, UPC 3 09047 25761 4
- Lots / codes affected
- Lot: M04145 Exp. 01/2024
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.